527 related articles for article (PubMed ID: 31298319)
1. Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.
Liu JG; Wang HB; Wan G; Yang MZ; Jiang XJ; Yang JY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5675-5681. PubMed ID: 31298319
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA ZFPM2-AS1 regulates renal cell carcinoma progression via miR-130a-3p/ESCO2.
Zhang G; Liu SL; Yi WT; Dong YP; Wan YX
Kaohsiung J Med Sci; 2022 Jun; 38(6):530-541. PubMed ID: 35258173
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
5. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
Wu C; Zhang J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA ZFPM2-AS1 Knockdown Restrains the Development of Retinoblastoma by Modulating the MicroRNA-515/HOXA1/Wnt/β-Catenin Axis.
Lyv X; Wu F; Zhang H; Lu J; Wang L; Ma Y
Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):41. PubMed ID: 32561925
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
[TBL] [Abstract][Full Text] [Related]
8. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
9. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504.
Chen Q; Fu L
PLoS One; 2020; 15(1):e0227568. PubMed ID: 31929567
[TBL] [Abstract][Full Text] [Related]
11. LncRNA ZFPM2-AS1 drives the progression of nasopharyngeal carcinoma via modulating the downstream miR-3612/DTL signaling.
Chang X; Jian L
Anticancer Drugs; 2022 Jul; 33(6):523-533. PubMed ID: 35276693
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DNAJC3-AS1 functions as oncogene in renal cell carcinoma via regulation of the miR-27a-3p/PRDM14 axis.
Na XY; Hu XQ; Zhao Y; Hu CH; Shang XS
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1291-1301. PubMed ID: 33629299
[TBL] [Abstract][Full Text] [Related]
13. LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma.
Dasgupta P; Kulkarni P; Majid S; Hashimoto Y; Shiina M; Shahryari V; Bhat NS; Tabatabai L; Yamamura S; Saini S; Tanaka Y; Dahiya R
Cell Death Dis; 2020 Aug; 11(8):660. PubMed ID: 32814766
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
15. lncRNA ZFPM2-AS1 promotes retinoblastoma progression by targeting microRNA miR-511-3p/paired box protein 6 (PAX6) axis.
Ni W; Li Z; Ai K
Bioengineered; 2022 Jan; 13(1):1637-1649. PubMed ID: 34989314
[TBL] [Abstract][Full Text] [Related]
16. STAT1-induced regulation of lncRNA ZFPM2-AS1 predicts poor prognosis and contributes to hepatocellular carcinoma progression via the miR-653/GOLM1 axis.
Zhang XW; Li QH; Xu ZD; Dou JJ
Cell Death Dis; 2021 Jan; 12(1):31. PubMed ID: 33414427
[TBL] [Abstract][Full Text] [Related]
17. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
18. ZFPM2-AS1 facilitates cell growth in esophageal squamous cell carcinoma via up-regulating TRAF4.
Sun G; Wu C
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32065218
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
[TBL] [Abstract][Full Text] [Related]
20. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
Yang Y; Dong MH; Hu HM; Min QH; Xiao L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]